Drug intelligence / Profile preview

Qishao Tianxin

Development stage: Preclinical
Administration: Oral

Overview

Qishao Tianxin is a traditional Chinese medicine (TCM) prescription investigated for its therapeutic effects, particularly in the context of early urinary incontinence following radical prostatectomy for prostate cancer. The formulation is referenced as a "prescription" rather than a single chemical entity, indicating it is likely a combination of herbal ingredients typical of TCM practice. Its mechanism of action has not been fully elucidated in Western pharmacological terms but may involve modulation of inflammation, tissue repair, and urogenital function based on TCM principles. Clinical research has been conducted to evaluate its efficacy and safety for post-surgical urinary complications[9].

Brand names: Qishao Tianxin
Other names: Qishao Tianxin prescription

Beyond the preview

Go deeper on Qishao Tianxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qishao Tianxin.

Explore the full profile